Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

TScan Therapeutics Q1 EPS $(0.67) Up From $(6.49) YoY

TScan Therapeutics (NASDAQ:TCRX) reported quarterly losses of $(0.67) per share. This is a 89.68 percent increase over losses of $(6.49) per share from the same period last year.
byBill Haddad
May 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

TScan Therapeutics (NASDAQ:TCRX) reported quarterly losses of $(0.67) per share. This is a 89.68 percent increase over losses of $(6.49) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For Acutus Medical

By Benzinga Insights
Today, 10:30 AM
Acutus Medical (NASDAQ:AFIB) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that Acutus Medical will report an earnings per share (EPS) of $-0.83.

AFIB